Carl Zeiss Meditec presented figures for the first nine months of the 2019/2020 financial year today. The turnover of the Jenauer company fell from 1.03 billion euros to 0.97 billion euros. Before interest and taxes, the east German company reports a profit decline from 184 million euros to 112 million euros. The EBIT margin fell from 17.9 percent to 11.6 percent. Per Carl Zeiss Meditec share a profit of EUR 0.77 was achieved after EUR 1.22 in the first nine months of the past fiscal year.
“In the third quarter of 2019/20 in particular, we were significantly affected by the effects of the COVID-19 pandemic. While business has already recovered slightly in parts of the APAC region, the measures to contain the COVID-19 pandemic in Europe and North America had a strong impact on our customers and thus also on the demand for our products, ”says Ludwin Monz , CEO of Carl Zeiss Meditec AG, on the course of business.
The company confirms the sales outlook. Carl Zeiss Meditec expects sales of around 1.3 billion euros. “We are assuming that the markets will continue to recover and that no additional measures will be required to contain the COVID-19 pandemic,” said Monz.
At a glance – chart and news: Carl Zeiss Meditec